vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and STEM, INC. (STEM). Click either name above to swap in a different company.

STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $30.9M, roughly 1.5× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -33.9%, a 80.5% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 2.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

CHCT vs STEM — Head-to-Head

Bigger by revenue
STEM
STEM
1.5× larger
STEM
$47.1M
$30.9M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+21.2% gap
CHCT
5.6%
-15.6%
STEM
Higher net margin
CHCT
CHCT
80.5% more per $
CHCT
46.6%
-33.9%
STEM
Faster 2-yr revenue CAGR
STEM
STEM
Annualised
STEM
36.1%
2.7%
CHCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCT
CHCT
STEM
STEM
Revenue
$30.9M
$47.1M
Net Profit
$14.4M
$-16.0M
Gross Margin
48.9%
Operating Margin
-17.7%
Net Margin
46.6%
-33.9%
Revenue YoY
5.6%
-15.6%
Net Profit YoY
687.6%
68.8%
EPS (diluted)
$0.52
$-4.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
STEM
STEM
Q4 25
$30.9M
$47.1M
Q3 25
$31.1M
$38.2M
Q2 25
$29.1M
$38.4M
Q1 25
$30.1M
$32.5M
Q4 24
$29.3M
$55.8M
Q3 24
$29.6M
$29.3M
Q2 24
$27.5M
$34.0M
Q1 24
$29.3M
$25.5M
Net Profit
CHCT
CHCT
STEM
STEM
Q4 25
$14.4M
$-16.0M
Q3 25
$1.6M
$-23.8M
Q2 25
$-12.6M
$202.5M
Q1 25
$1.6M
$-25.0M
Q4 24
$1.8M
$-51.1M
Q3 24
$1.7M
$-148.3M
Q2 24
$-10.4M
$-582.3M
Q1 24
$3.7M
$-72.3M
Gross Margin
CHCT
CHCT
STEM
STEM
Q4 25
48.9%
Q3 25
35.5%
Q2 25
33.4%
Q1 25
32.4%
Q4 24
-4.4%
Q3 24
21.2%
Q2 24
27.6%
Q1 24
-95.0%
Operating Margin
CHCT
CHCT
STEM
STEM
Q4 25
-17.7%
Q3 25
-33.6%
Q2 25
-34.8%
Q1 25
-65.0%
Q4 24
-84.4%
Q3 24
-493.2%
Q2 24
-1705.5%
Q1 24
-267.0%
Net Margin
CHCT
CHCT
STEM
STEM
Q4 25
46.6%
-33.9%
Q3 25
5.3%
-62.2%
Q2 25
-43.2%
527.8%
Q1 25
5.3%
-76.9%
Q4 24
6.3%
-91.6%
Q3 24
5.9%
-506.3%
Q2 24
-37.9%
-1712.6%
Q1 24
12.5%
-283.9%
EPS (diluted)
CHCT
CHCT
STEM
STEM
Q4 25
$0.52
$-4.40
Q3 25
$0.03
$-2.84
Q2 25
$-0.50
$-1.79
Q1 25
$0.03
$-0.15
Q4 24
$0.04
$-15.29
Q3 24
$0.04
$-18.24
Q2 24
$-0.42
$-71.81
Q1 24
$0.11
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
STEM
STEM
Cash + ST InvestmentsLiquidity on hand
$3.3M
$48.9M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
$-249.4M
Total Assets
$990.8M
$308.9M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
STEM
STEM
Q4 25
$3.3M
$48.9M
Q3 25
$3.4M
$43.1M
Q2 25
$4.9M
$40.8M
Q1 25
$2.3M
$58.6M
Q4 24
$4.4M
$56.3M
Q3 24
$2.8M
$75.4M
Q2 24
$734.0K
$89.6M
Q1 24
$3.8M
$112.8M
Total Debt
CHCT
CHCT
STEM
STEM
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
CHCT
CHCT
STEM
STEM
Q4 25
$429.4M
$-249.4M
Q3 25
$426.8M
$-235.7M
Q2 25
$437.8M
$-214.1M
Q1 25
$461.3M
$-417.5M
Q4 24
$476.0M
$-398.4M
Q3 24
$477.2M
$-344.1M
Q2 24
$497.8M
$-203.2M
Q1 24
$511.6M
$371.6M
Total Assets
CHCT
CHCT
STEM
STEM
Q4 25
$990.8M
$308.9M
Q3 25
$987.3M
$362.6M
Q2 25
$966.3M
$379.2M
Q1 25
$985.1M
$405.1M
Q4 24
$992.6M
$437.4M
Q3 24
$981.8M
$537.8M
Q2 24
$983.2M
$691.5M
Q1 24
$982.7M
$1.3B
Debt / Equity
CHCT
CHCT
STEM
STEM
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
STEM
STEM
Operating Cash FlowLast quarter
$56.4M
$8.2M
Free Cash FlowOCF − Capex
$35.9M
FCF MarginFCF / Revenue
116.0%
Capex IntensityCapex / Revenue
66.3%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
STEM
STEM
Q4 25
$56.4M
$8.2M
Q3 25
$12.7M
$11.4M
Q2 25
$13.8M
$-21.3M
Q1 25
$14.4M
$8.5M
Q4 24
$58.9M
$-14.7M
Q3 24
$13.8M
$-9.4M
Q2 24
$16.7M
$-11.9M
Q1 24
$12.6M
$-621.0K
Free Cash Flow
CHCT
CHCT
STEM
STEM
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
Q1 25
$9.7M
Q4 24
$34.2M
Q3 24
$6.7M
Q2 24
$9.5M
Q1 24
$7.5M
FCF Margin
CHCT
CHCT
STEM
STEM
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
Q1 25
32.3%
Q4 24
116.9%
Q3 24
22.5%
Q2 24
34.7%
Q1 24
25.7%
Capex Intensity
CHCT
CHCT
STEM
STEM
Q4 25
66.3%
Q3 25
16.3%
Q2 25
14.5%
Q1 25
15.6%
Q4 24
84.1%
Q3 24
24.2%
Q2 24
26.1%
Q1 24
17.4%
Cash Conversion
CHCT
CHCT
STEM
STEM
Q4 25
3.91×
Q3 25
7.76×
Q2 25
-0.11×
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons